Use of Bone-Modifying Agents Following Androgen Deprivation Therapy for Medicare Non-Metastatic Prostate Cancer Patients

May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.574
https://www.valueinhealthjournal.com/article/S1098-3015(14)00625-1/fulltext
Section Title : Cancer
Section Order : 1626
First Page : A99
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00625-1&doi=10.1016/j.jval.2014.03.574
HEOR Topics :
Tags :
Regions :